Induction of p53 Renders ATM-Deficient Mice Refractory to Hepatocarcinogenesis

Gastroenterology

Volumn 138, Issue 3, 2010, Pages

  Teoh, Narci ^a   Pyakurel, Pawan ^a   Dan, Yock Young ^b   Swisshelm, Karen ^c   Hou, Jing ^a   Mitchell, Claudia ^d   Fausto, Nelson ^d   Gu, Yansong ^d   Farrell, Geoffrey ^a  

^a The Australian National University   (Australia)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

ATM; Hepatocellular Carcinoma; p53

Indexed keywords

ATM PROTEIN; ATR PROTEIN; BETA GALACTOSIDASE; CASPASE 3; CHECKPOINT KINASE 1; CXCL1 CHEMOKINE; DIETHYLNITROSAMINE; PROTEIN P19; PROTEIN P53; TELOMERASE;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL CYCLE PROGRESSION; CELL IMMORTALIZATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; ENZYME ACTIVITY; HETEROZYGOTE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; UPREGULATION;

EID: 77249163207     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.11.008     Document Type: Article

References (23)

1. El-Serag H.B., and Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132 (2007) 2557-2576
2. Bruix J., Boix J., Sala M., et al. Focus on hepatocellular carcinoma. Cancer Cell (2004) 215-219
3. Farazi P.A., and DePinho R.A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6 (2006) 674-687
4. Aihara T., Noguchi S., Sasaki Y., et al. Clonal analysis of precancerous lesions of hepatocellular carcinoma. Gastroenterology 111 (1996) 455-461
5. De Souza A.T., Hankins G.R., Washington M.K., et al. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 11 (1995) 447-449
6. Khanna K.K., and Jackson S.P. DNA double-strand breaks: signalling, repair and the cancer connection. Nat Genet 27 (2001) 247-254
7. Van Gent D.C., Hoeijmakers J.H.J., and Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet 2 (2001) 196-206
8. Teoh N., Dan Y.Y., Swisshelm K., et al. Defective Ku70 DNA double strand break repair enhances hepatocarcinogenesis in mice. Hepatology 47 (2008) 2078-2088
9. Loyer P., Glaise D., Cariou S., et al. Expression and activation of cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J Biol Chem 269 (1994) 2491-2500
10. Buitrago-Molina L.E., Pothiraju D., Lamle J., et al. Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage. Hepatology 50 (2009) 500
11. Vousden K.H., and Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2 (2002) 594-604
12. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3 (2003) 155-168
13. Zhao H., and Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol 21 (2001) 4129-4139
14. Cortez D., Guntuku S., Qin J., et al. ATR and ATRiP: partners in checkpoint signalling. Science 294 (2001) 1713-1716
15. Edwards R., Bentley N.J., and Carr A.M. A Rad3-Rad26 complex responds to DNA damage independently of other checkpoint proteins. Nat Cell Biol 1 (1999) 393-398
16. Cortez D., Wang Y., Qin J., et al. Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double strand breaks. Science 286 (1999) 1162-1166
17. Lee J.S., and Thorgeirsson S.S. Genome scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction and identification of therapeutic targets. Gastroenterology 127 (2004) S51-S55
18. Westphal C.H., Rowan S., Schmaltz C., et al. atm and p53 Cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat Genet 16 (1997) 397-401
19. Xue W., Zender L., Miething C., et al. Senescence and tumor clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007) 656-660
20. Ventura A., Kirsch D.G., McLaughlin M.E., et al. Restoration of p53 leads to tumor regression in vivo. Nature 445 (2007) 661-665
21. Jiang X.R., Jimenez G., Chang E., et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 21 (1999) 111-114
22. Satyanarayana A., Manns M.P., and Rudolph K.L. Telomeres and telomerase: a dual role in hepatocarcinogenesis. Hepatology 40 (2004) 276-283
23. Wong K.-K., Maser R., Bachoo R.M., et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421 (2003) 643-647